Dr Eilís Dowd’s research is focused on developing and validating novel pharmacological, cell, gene and biomaterial therapies for Parkinson’s disease. She received her PhD at the University of Edinburgh, UK, after which she completed post-doctoral research at the University of Cambridge, UK, McGill University, Canada and Cardiff University, UK. She then returned to her home country of Ireland in September 2005 to take-up a tenured position where she is now Senior Lecturer in Pharmacology at National University of Ireland, Galway.
Dr Dowd is Immediate Past President of Neuroscience Ireland, Ireland’s official neuroscience society, and Immediate Past President of the Network for European CNS Transplantation and Restoration (NECTAR). She sits on the Governing Councils of both the Federation of European Neuroscience Societies (FENS) and the International Brain Research Organisation (IBRO). She is also Associate Editor of Neuronal Signaling, Section Editor of the European Journal of Neuroscience, and Editorial Board member at the British Journal of Pharmacology.